z-logo
open-access-imgOpen Access
Long-Term Effectiveness and Safety of Childhood Growth Hormone Treatment in Noonan Syndrome
Author(s) -
Tilman Rohrer,
Jennifer Abuzzahab,
Philippe Backeljauw,
Anna Camilla Birkegård,
Joanne Blair,
Jovanna Dahlgren,
Pétur Benedikt Júlíusson,
Vlady Ostrow,
Alberto Pietropoli,
Michel Polak,
Alicia Romanò,
Judith L. Ross,
Lars Sävendahl,
Bradley S. Miller
Publication year - 2020
Publication title -
hormone research in paediatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.816
H-Index - 89
eISSN - 1663-2826
pISSN - 1663-2818
DOI - 10.1159/000512429
Subject(s) - medicine , noonan syndrome , gastroenterology , adverse effect , pediatrics , endocrinology
Few data exist on long-term growth hormone (GH) treatment in patients with Noonan syndrome (NS).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom